ArticleFrontiers in immunology2025

Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway.

Xinxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.